Related Experiment Videos
Metronidazole resistant trichomoniasis successfully treated with paromomycin
1Department of G U Medicine, St John's Hospital, Chelmsford, Essex.
Genitourinary Medicine
|April 16, 1998
Summary
A patient with resistant trichomoniasis (a sexually transmitted infection) did not respond to metronidazole treatments. Topical paromomycin successfully treated the infection, offering a new therapeutic option.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Trichomoniasis, a common sexually transmitted infection, is typically treated with metronidazole.
- Metronidazole resistance in Trichomonas vaginalis is an emerging clinical challenge.
- Standard and high-dose metronidazole therapies failed in this patient.
Observation:
- A 42-year-old female patient presented with persistent trichomoniasis.
- The causative organism demonstrated resistance to metronidazole via Minimum Inhibitory Concentration (MIC) testing.
- Previous treatment failures included oral and topical metronidazole, as well as other reported options for resistant cases.
Findings:
- Successful treatment of metronidazole-resistant trichomoniasis was achieved using topical intravaginal paromomycin.
- This case highlights the potential of paromomycin as an alternative therapeutic agent.
Implications:
- Topical paromomycin represents a viable alternative for managing refractory cases of trichomoniasis.
- Further research into paromomycin's efficacy and safety for trichomoniasis is warranted.
- This finding contributes to the understanding of antimicrobial resistance in sexually transmitted infections.